|
|
|
11.06.25 - 14:03
|
HYTN Receives Initial International Purchase Order for GMP Vape Cartridges (GlobeNewswire EN)
|
|
VANCOUVER, British Columbia, June 11, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a leader in pharmaceutical-grade cannabis manufacturing, is pleased to announce that it has received its first purchase order and import permit for Good Manufacturing Practices (GMP) cannabis vape cartridges (the “Products” or “Vapes”). This milestone follows the Company's January 21 news release detailing a collaboration agreement with SNDL to develop GMP-compliant vape cartridges....
|
|
|
|
|
|
|
|
|
|
11.04.25 - 13:01
|
SNDL Announces Listing on the CSE (PR Newswire)
|
|
EDMONTON, AB, April 11, 2025 /PRNewswire/ - SNDL Inc. (Nasdaq: SNDL) (CSE: SNDL) ("SNDL" or the "Company") announces that its common shares have commenced trading on the Canadian Securities Exchange (the "CSE") under the symbol "SNDL", effective April 11, 2025. The CSE listing will......
|
|
11.04.25 - 00:12
|
CSE Bulletin: New Listing - SNDL Inc. (SNDL) (Newsfile)
|
|
Toronto, Ontario--(Newsfile Corp. - Le 10 avril/April 2025) - The common shares of SNDL Inc. have been approved for listing on the CSE. Listing and disclosure documents will be available at www.th......
|
|
|
|
|
29.03.25 - 01:03
|
HYTN Secures Strategic Supply Agreements and Qualifies 4000kg of Cannabis for German Market (GlobeNewswire EN)
|
|
VANCOUVER, British Columbia, March 28, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) ("HYTN" or the "Company"), a leader in pharmaceutical-grade cannabis manufacturing, is pleased to announce it has entered into strategic supply agreements (the “Agreements”) and successfully completed vendor qualification with two cannabis cultivators under its Good Manufacturing Practice (GMP) system qualifying a minimum of 4000 kg of cannabis for the German market. This milestone builds on HYTN's recent announcements outlining its strategic transition into international pharmaceutical sales, including partnerships with SNDL Inc (SNDL) and 4C Labs, and further strengthens its manufacturing scope, positioning the Company for continued global expansion....
|
|
|
|
|